Barach Daniele Wolf Sells Shares of CELU
Insider Barach Daniele Wolf offloads 839,160 shares of CELU.
Key Points
- Barach Daniele Wolf sold 839,160 shares of CELU on June 19, 2026, with no specified transaction value.
- CELU shares traded at $0.76 on Tuesday with several institutional investors adjusting their positions.
- Analysts from WBB Securities upgraded CELU to a 'buy' with a $6 target, reflecting varied sentiment.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Barach Daniele Wolf sold 839,160 shares of CELU on June 19, 2026. The transaction did not specify a dollar value. This sale was not part of a pre-arranged trading plan.
Other Institutional Activity in CELU
Several institutional investors have recently adjusted their positions in CELU. C V Starr & Co Inc maintained its holdings with 764,069 shares valued at about $1,016,212. Vanguard Capital Management LLC opened a new position with 621,105 shares worth approximately $826,070. Geode Capital Management, LLC increased its stake by 30,886 shares, now holding 191,076 shares valued at $254,171, marking a 19.3% increase. BlackRock, Inc. added 12,646 shares, bringing its total to 127,501 shares worth around $169,575, an 11.0% increase. Vanguard Fiduciary Trust Co also initiated a new position with 79,874 shares valued at $106,232.
Celularity Inc. Stock Down 55.7%
Shares of CELU traded at $0.76 on Tuesday. CELU's stock movements have been closely watched, with its current market sentiment influenced by insider sales and institutional adjustments.
$CELU stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Celularity Inc.
On June 19, 2026, several insiders, including Barach Daniele Wolf and the Philip Daniele Barach Family Trust, sold substantial amounts of CELU shares. Each transaction was unplanned, and no specific transaction prices were disclosed.
Analysts Set New Price Targets
Analysts have varied opinions on CELU. On September 9, 2025, WBB Securities upgraded the stock to a 'buy' with a price target of $6. Earlier, on August 18, 2025, the same firm initiated coverage with a 'buy' rating and the same target. H.C. Wainwright maintained a 'buy' rating with a $2.5 target on May 25, 2023, and a $15 target on January 11, 2023. Meanwhile, Morgan Stanley downgraded CELU to 'sell' with a $1 target on January 30, 2023.
Bottom Line
The recent insider sales by Barach Daniele Wolf and others highlight ongoing changes in CELU's ownership. Institutional investors have shown mixed activity, with some initiating new positions. Analyst opinions are also split, with recent upgrades and downgrades reflecting diverse market views. As always, it's important to note that insider transactions and 13F filings are backward-looking and may not represent current sentiment.
Get Celularity Inc. alerts
New 13F filings, insider trades, and analyst moves on $CELU, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.